Professeure, Faculté de médecine et des sciences de la santé
FMSS Dép. d'immunologie et de biologie cellulaire
(2002) Post-doctorate (Science). The Research Institute of the McGill University Health Centre.
(1997) Doctorate (Science). McGill University.
(1989) Bachelor's (Science). McGill University.
(2011) Associate Professor. Université de Sherbrooke.
(2015-2019) Director of the Graduate Cell Biology Programs. Université de Sherbrooke.
(2011-2015) Coordinator, Conference & Seminar Series, Department of Anatomy and Cell Biology & Cell Biology Programs. Université de Sherbrooke.
(2007-2011) Assistant Professor. Université de Sherbrooke.
(2002-2007) Research Associate (Laboratory of Dr. Morag Park). The Research Institute of the McGill University Health Centre.
Cell Signaling and Cancer, Biological and Biochemical Mechanisms, Carcinogenesis, Digestive System, Host-Tumour Interaction.
Oncology, Cell Biology.
Cancer, Receptor Tyrosine Kinase, Cell Signaling, Angiogenesis, Tumorigenesis, Metastasis, Cancer Mouse Models, Colorectal cancer, Inflammatory bowel disease.
My research interest is to understand the molecular signaling events and biological processes regulated by growth factor receptor tyrosine kinases contributing to the initiation and progression of cancer.
Centre de recherche du CHUS
Anglais, Français
Grant. (Awarded). Principal Investigator. Epithelial cell-specific role of SOCS1 in prevention of intestinal inflammation. Canadian Institutes of Health Research (CIHR). Project Grant. 787950 $ (2019-2024).
Grant. (Awarded). Principal Applicant. Non-canonical role of initiator caspases in colorectal cancer. Canadian Institutes of Health Research (CIHR). Project Grant. 669375 $ (2019-2024).
Grant. (Awarded). Principal Investigator. MET and p66SHC interactomes and functions. Natural Sciences and Engineering Research Council of Canada (NSERC). Discovery Grant. 130000 $ (2017-2022).
Grant. (Completed). Co-applicant. CIACCO-2019 (8th Annual symposium on Cytokines in Inflammation, Ageing, CanCer and Obesity). Canadian Institutes of Health Research (CIHR). Planning and Dissemination Grant. 10000 $ (2018-2019).
Grant. (Completed). Principal Applicant. Rôle oncogénique des caspases. Centre de Recherche du Centre Hospitalier de l'Université de Sherbrooke Inc. (CRCHUS) (Sherbrooke, QC). Programme d’aide au financement interne. 10000 $ (2018-2019).
Grant. (Completed). Principal Applicant. Développement d’anticorps spécifiques aux formes clivées par les caspases initiatrices de sortin nexin 1 et 2. Centre de protéomique structurale et fonctionnelle des protéomes de l’Université de Sherbrooke. Projets collaboratifs PROTEOMEUS. 8000 $ (2018-2019).
Grant. (Completed). Principal Applicant. Rôle intrinsèque de SOCS1 dans l’épithélium intestinal et l'inflammation. Centre de recherche en inflammation et oncologie digestive de l’UdeS. Operating Grant. 15000 $ (2017-2018).
Grant. (Completed). Co-applicant. Blocking Molecular Movement of the NHE6 Exchanger Could Lead to New Way to Treat Breast Cancer. (2015-2016).
Grant. (Completed). Principal Investigator. Impact de la délétion de SOCS1 dans l’épithélium intestinal. (2013-2015).
Grant. (Completed). Principal Investigator. Role of Receptor Tyrosine Kinases in the Initiation and Progression of Colorectal Cancer. Canadian Institutes of Health Research (CIHR). Operating Grant. 657990 $ (2010-2015).
Grant. (Completed). Principal Investigator. Évaluation pré-clinique de l'effet préventif et thérapeutique de monoglycérides dérivés d'oméga-3 dans le cancer colorectal. (2011-2013).
Grant. (Completed). Co-investigator. Regulation of Met Signaling by Socs1 in Hepatocellular Carcinoma. (2011-2013).
Grant. (Completed). Principal Investigator. The Role of Met Receptor in Morphogenesis and Renewal of the Intestinal Epithelium. (2008-2013).
Grant. (Completed). Principal Investigator. Évaluation comparative des propriétés biologiques des monoglycérides de DHA et EPA dans le cancer colorectale. (2011).
Grant. (Completed). Co-investigator. Wake up of Dormant Metastatic Breast Cancer Cells by Radiation: Prevention with a COX-2 Inhibitor. (2010-2011).
Grant. (Completed). Co-applicant. Colloque "Signalisation Québec 2010". (2010).
Grant. (Completed). Principal Investigator. Role of Shc in the Development and Progression of Colorectal Cancer. (2007-2010).
Grant. (Completed). Principal Applicant. Étude des mécanismes moléculaires et cellulaires impliqués dans les physiopathologies de l'épithélium intestinal. (2008-2009).
Grant. (Completed). Principal Applicant. Étude des mécanismes moléculaires et cellulaires impliqués dans les physiopathologies de l'épithélium intestinal. (2008-2009).
Grant. (Completed). Principal Investigator. The Role of Met Receptor in Morphogenesis and Renewal of the Intestinal Epithelium. (2007-2008).
Grant. (Completed). Co-applicant. Shc in Breast Tumor Angiogenesis. (2005-2008).
Les informations disponibles dans la base de données Expertus sont tirées du CV commun canadien.